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Boot et al. describe a case of hepatitis B vaccination
failure in a healthcare worker [1]. According to this re-
port, the case belongs to two risk groups for hepatitis
B virus (HBV) infection: healthcare workers and male
homosexuals. The report presents a history of unsafe
sex with at least ﬁve male partners in the six months
prior to the acute infection and no details about occupa-
tional exposures. In addition, the molecular epidemiol-
ogy is that of a HBV isolate prevalent among men
who have sex with men (MSM) in the Netherlands.
The authors state that ‘‘Healthcare workers [HCWs]
whose response to the initial hepatitis B vaccination is
moderate might be vulnerable to hepatitis B virus infec-
tion”. However, this case report is not about occupa-
tionally acquired hepatitis B infection but rather about
sexually transmitted infection from sexual exposure.
Furthermore, there are host factors that indicate some
immunological dysfunction. The patient had ‘‘re-
sponded only marginally” to his primary vaccination
series (anti-HBs = 10 sample ratio units). In addition,
the patient had a reverse CD4:CD8 ratio with decreased
T-cell responsiveness against mitogens.
Hepatitis B vaccine provides at least 15 years of pro-
tection, as demonstrated in a randomized controlled
trial of children vaccinated at birth [2], and at least 10
years of protection in HCWs [3]. Policy makers shouldAcute hepatitis B in a healthcar
of failure of hepatcontinue to be vigilant about the potential for break-
through infections, however, they should also remain as-
sured of the excellent performance of this vaccine in the
occupational health setting. Behavior change should
continue to be seen as an important protective measure
in MSM, especially when immune dysfunction could
blunt the response to vaccination.
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itis B vaccinationTo the Editor:
In response to our case report of an acute HBV infec-
tion in a vaccinated male nurse [1], Dr. S. Wiersma of
the WHO [2] argues that our patient had multiple
HBV exposure risks, and that HBV acquisition via the
hospital setting is less likely than acquisition via sexual
exposure in this particular case. We agree with his view
that unsafe homosexual contacts in the months preced-
ing the acute HBV infection are the most likely source
of infection. However, it is not the source of infection
that is the important issue here, but the fact that a fully
vaccinated person, registered as being HBV protected,
can be a source of HBV transmission to others, and, if
the person is a healthcare worker, a source within a hos-
pital. We agree that, at the moment, there is no need torevise the policy for healthcare-speciﬁc HB vaccination.
However, as also stated by Dr. Wiersma [2], we must be
aware of the fact that vaccinees, including healthcare
workers, might become infected with HBV despite a
documented adequate response to an HB vaccine in
the past. This might become a more prominent feature
when individuals who were vaccinated against HBV as
neonates start working in the healthcare setting. If and
why this speciﬁc patient was predisposed to become
HBV infected remains unclear. Were his poor-to-moder-
ate responses to the successive HB-plasma vaccines the
reason for his vulnerability, or is his unbalanced im-
mune response involved, or is it a combination of both?
As we have stressed in the Discussion section of our pa-
per [1], it is not easy to recognize secondaryHBvaccination
